Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- PMID: 32268022
- PMCID: PMC7161262
- DOI: 10.1056/NEJMc2007575
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Abstract
The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covid-19 who were also seen in the same intensive care unit. Coagulopathy and antiphospholipid antibodies were seen in all three patients.
Comment in
-
COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?Rev Neurol (Paris). 2020 Jun;176(6):505-506. doi: 10.1016/j.neurol.2020.05.001. Epub 2020 May 8. Rev Neurol (Paris). 2020. PMID: 32409176 Free PMC article. No abstract available.
-
COVID-19 cardiac involvement in a 38-day old infant.Pediatr Pulmonol. 2020 Aug;55(8):1879-1881. doi: 10.1002/ppul.24895. Epub 2020 Jun 18. Pediatr Pulmonol. 2020. PMID: 32558285 Free PMC article.
-
Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).Int J Lab Hematol. 2020 Dec;42(6):e280-e282. doi: 10.1111/ijlh.13320. Epub 2020 Aug 26. Int J Lab Hematol. 2020. PMID: 32851784 Free PMC article. No abstract available.
References
-
- Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002;31(4):256-263. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical